Broder MS - Search Results

1

Untangling the clinical and economic burden of hospitalization for cardiac amyloidosis in the United States.

Quock TP, Yan T, Tieu R, D'Souza A, Broder MS. Quock TP, et al. Among authors: broder ms. Clinicoecon Outcomes Res. 2019 Jul 15;11:431-439. doi: 10.2147/CEOR.S207127. eCollection 2019. Clinicoecon Outcomes Res. 2019. PMID: 31410040 Free PMC article.

2

Health and economic outcomes associated with uncontrolled surgical bleeding: a retrospective analysis of the Premier Perspectives Database.

Corral M, Ferko N, Hollmann S, Broder MS, Chang E. Corral M, et al. Among authors: broder ms. Clinicoecon Outcomes Res. 2015 Jul 22;7:409-21. doi: 10.2147/CEOR.S86369. eCollection 2015. Clinicoecon Outcomes Res. 2015. PMID: 26229495 Free PMC article.

3

Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis.

Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK. Luskin AT, et al. Among authors: broder ms. Clinicoecon Outcomes Res. 2016 Oct 25;8:641-648. doi: 10.2147/CEOR.S115025. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27822075 Free PMC article.

4

Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder.

Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS. Greene M, et al. Among authors: broder ms. J Med Econ. 2018 Feb;21(2):127-134. doi: 10.1080/13696998.2017.1379412. Epub 2017 Sep 29. J Med Econ. 2018. PMID: 28895758 Free article.

5

All-cause hospitalization and associated costs in patients with schizophrenia or bipolar disorder initiating long-acting injectable antipsychotics.

Yan T, Greene M, Chang E, Hartry A, Touya M, Broder MS. Yan T, et al. Among authors: broder ms. Curr Med Res Opin. 2018 Jan;34(1):41-47. doi: 10.1080/03007995.2017.1395733. Epub 2017 Nov 3. Curr Med Res Opin. 2018. PMID: 29057674

6

Predictive factors associated with carcinoid syndrome in patients with gastrointestinal neuroendocrine tumors.

Cai B, Broder MS, Chang E, Yan T, Metz DC. Cai B, et al. Among authors: broder ms. World J Gastroenterol. 2017 Oct 28;23(40):7283-7291. doi: 10.3748/wjg.v23.i40.7283. World J Gastroenterol. 2017. PMID: 29142475 Free PMC article.

7

The Cost of Hematopoietic Stem-Cell Transplantation in the United States.

Broder MS, Quock TP, Chang E, Reddy SR, Agarwal-Hashmi R, Arai S, Villa KF. Broder MS, et al. Am Health Drug Benefits. 2017 Oct;10(7):366-374. Am Health Drug Benefits. 2017. PMID: 29263771 Free PMC article.

8

Healthcare resource utilization and costs in amyloid light-chain amyloidosis: a real-world study using US claims data.

Quock TP, Yan T, Chang E, Guthrie S, Broder MS. Quock TP, et al. Among authors: broder ms. J Comp Eff Res. 2018 Jun;7(6):549-559. doi: 10.2217/cer-2017-0100. Epub 2018 Feb 2. J Comp Eff Res. 2018. PMID: 29390860 Free article.

9

First-line systemic treatment adherence, healthcare resource utilization, and costs in patients with gastrointestinal neuroendocrine tumors (GI NETs) in the USA.

Broder MS, Cai B, Chang E, Yan T, Benson AB 3rd. Broder MS, et al. J Med Econ. 2018 Aug;21(8):821-826. doi: 10.1080/13696998.2018.1474748. Epub 2018 May 25. J Med Econ. 2018. PMID: 29741466 Free article.

10

Epidemiology of AL amyloidosis: a real-world study using US claims data.

Quock TP, Yan T, Chang E, Guthrie S, Broder MS. Quock TP, et al. Among authors: broder ms. Blood Adv. 2018 May 22;2(10):1046-1053. doi: 10.1182/bloodadvances.2018016402. Blood Adv. 2018. PMID: 29748430 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters